Direkt zum Inhalt
Merck
  • Proposed actions for the US Food and Drug Administration to implement to minimize adverse effects associated with energy drink consumption.

Proposed actions for the US Food and Drug Administration to implement to minimize adverse effects associated with energy drink consumption.

American journal of public health (2014-05-17)
Janet Thorlton, David A Colby, Paige Devine
ZUSAMMENFASSUNG

Energy drink sales are expected to reach $52 billion by 2016. These products, often sold as dietary supplements, typically contain stimulants. The Dietary Supplement Protection Act claims an exemplary public health safety record. However, in 2011 the number of emergency department visits related to consumption of energy drinks exceeded 20,000. Nearly half of these visits involved adverse effects occurring from product misuse. Political, social, economic, practical, and legal factors shape the landscape surrounding this issue. In this policy analysis, we examine 3 options: capping energy drink caffeine levels, creating a public education campaign, and increasing regulatory scrutiny regarding the manufacture and labeling of energy drinks. Increased regulatory scrutiny may be in order, especially in light of wrongful death lawsuits related to caffeine toxicity resulting from energy drink consumption.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Koffein, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Koffein, powder, ReagentPlus®
Sigma-Aldrich
Koffein, anhydrous, 99%, FCC, FG
USP
Koffein, United States Pharmacopeia (USP) Reference Standard
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Coffein Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Koffein -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Koffein, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
USP
Koffein-Schmelzpunkt-Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Koffein, Sigma Reference Standard, vial of 250 mg
Supelco
Koffein -Lösung, analytical standard, 1.0 mg/mL in methanol
Sigma-Aldrich
Koffein, meets USP testing specifications, anhydrous
Supelco
Mettler Toledo Calibration Substance ME 18872, Caffeine, traceable to primary standards (LGC)
Sigma-Aldrich
Koffein, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Koffein, BioXtra
Koffein für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Koffein, European Pharmacopoeia (EP) Reference Standard